Traws Pharma, Inc. (TRAW)
0.416
-0.03
(-6.56%)
USD |
NASDAQ |
Oct 12, 16:00
0.42
0.00 (0.00%)
After-Hours: 07:23
Traws Pharma Total Liabilities (Quarterly) : 9.779M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.779M |
| March 31, 2026 | 13.47M |
| December 31, 2025 | 11.25M |
| September 30, 2025 | 7.898M |
| June 30, 2025 | 7.36M |
| March 31, 2025 | 13.06M |
| December 31, 2024 | 56.59M |
| September 30, 2024 | 10.97M |
| June 30, 2024 | 12.59M |
| March 31, 2024 | 12.16M |
| December 31, 2023 | 12.01M |
| September 30, 2023 | 12.52M |
| June 30, 2023 | 11.57M |
| March 31, 2023 | 12.18M |
| December 31, 2022 | 11.06M |
| September 30, 2022 | 10.41M |
| June 30, 2022 | 9.59M |
| March 31, 2022 | 9.135M |
| December 31, 2021 | 9.358M |
| September 30, 2021 | 10.32M |
| June 30, 2021 | 11.38M |
| March 31, 2021 | 11.70M |
| December 31, 2020 | 13.81M |
| September 30, 2020 | 12.99M |
| June 30, 2020 | 12.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.72M |
| December 31, 2019 | 12.10M |
| September 30, 2019 | 12.05M |
| June 30, 2019 | 13.13M |
| March 31, 2019 | 12.88M |
| December 31, 2018 | 12.54M |
| September 30, 2018 | 12.28M |
| June 30, 2018 | 14.29M |
| March 31, 2018 | 15.49M |
| December 31, 2017 | 15.84M |
| September 30, 2017 | 14.88M |
| June 30, 2017 | 15.66M |
| March 31, 2017 | 19.26M |
| December 31, 2016 | 18.11M |
| September 30, 2016 | 18.07M |
| June 30, 2016 | 14.16M |
| March 31, 2016 | 12.82M |
| December 31, 2015 | 12.60M |
| September 30, 2015 | 21.77M |
| June 30, 2015 | 23.16M |
| March 31, 2015 | 24.10M |
| December 31, 2014 | 23.72M |
| September 30, 2014 | 26.61M |
| June 30, 2014 | 25.63M |
| March 31, 2014 | 25.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.47M |
| Shareholders Equity (Quarterly) | 1.691M |
| Current Ratio | 0.9269 |